Sarda Proteins Reports Strong Profit Growth Amid Revenue Decline, Secures ₹83 Cr Equity Advance

Sarda Proteins Ltd. has reported a 31-fold surge in its standalone profit for the fiscal year ended March 31, 2026, reaching ₹63.79 lakh from ₹2.01 lakh in fiscal year 2025. This significant profit increase occurred despite a nearly 33% drop in revenue from operations, which fell to ₹1,615.84 lakh from ₹2,419.10 lakh in the previous year. The company also announced it secured an advance of ₹8,337.50 lakh (₹83.38 crore) against equity, pending formal share allotment. For the fourth quarter of FY26, the company turned a profit of ₹84.49 lakh, reversing a loss of ₹11.23 lakh in the same quarter last year.

Strategic Pivot Supported by Capital Infusion

The ₹83.38 crore advance signals a significant potential capital infusion, which could be critical for funding Sarda Proteins' strategic shift. The company is reportedly pivoting from its traditional edible oil business towards renewable energy and solar power generation, a move that this capital could help accelerate.

Profitability Boosted by Cost Management

The profit surge, despite the revenue dip, suggests Sarda Proteins enhanced its profitability through improved cost management or other operational efficiencies. Shareholders may benefit from improved earnings per share if these cost savings are sustained.

Company Background and Recent Changes

Established in 1991, Sarda Proteins has historically focused on the edible oil and agricultural commodities sector. The company has recently undergone strategic changes, including converting convertible warrants into equity shares in March 2026, raising over ₹62 crore. This move bolstered its capital structure, triggered an open offer, and led to a change in management control, underscoring efforts to fund future growth and strategic realignments.

Key Risks and Challenges Ahead

Key risks to monitor include the timely completion of the equity share allotment for the ₹83.38 crore advance. Additionally, the significant drop in revenue from operations raises questions about market demand or competitive pressures within its established business segments.

Peer Comparison and Financial Standing

Within the edible oil and agro-processing sector, Sarda Proteins' peers include Gokul Agro Resources Limited, Patanjali Foods Limited, and Gujarat Ambuja Exports Limited. However, Sarda Proteins shows lower financial stability compared to these peers, evidenced by a zero Altman Z-score. The company's stock performance has also historically lagged broader market benchmarks.

What to Track Next

Investors will be watching for the finalization of the equity share allotment related to the ₹83.38 crore advance. Key areas to track include the execution of its renewable energy diversification strategy, ongoing revenue and cost management in its core business, and any further announcements regarding its strategic pivot, such as name changes or relocation plans.